4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Sinco Pharmaceuticals Holdings Limited (6833) operates in the Medical Distribution industry and is headquartered in Chengdu, China with about 261 employees. Its market capitalization is roughly CNY 350 million. In the fiscal year ended 2024-12-31, 6833 reported CNY 2.8B in revenue and CNY 42M in net income.
Sinco Pharmaceuticals Holdings Limited, an investment holding company, provides marketing, promotion, and channel management services for imported pharmaceutical products and medical devices in China.
Interactive charts & full statements →
| Income statement | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Revenue | CNY 2.8B | CNY 2.5B | CNY 2.3B | CNY 2.0B |
| Gross Profit | CNY 300M | CNY 323M | CNY 306M | CNY 365M |
| Operating Income (EBIT) | CNY 117M | CNY 118M | CNY 101M | CNY 195M |
| Net Income | CNY 42M | CNY 42M | CNY 70M | CNY 135M |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Dividends Paid | (CNY 7M) | (CNY 18M) | — | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Assets | CNY 2.0B | CNY 1.9B | CNY 1.4B | CNY 1.2B |
| Total Liabilities | CNY 1.3B | CNY 1.3B | CNY 820M | CNY 858M |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 6833 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms